Axel Wester

Deeply honored and humbled to have received the investigator award @Apasl2024 in Kyoto 🇯🇵! A huge thanks to @schattenbergJ and the excellent collaboration with @HannesHagstrom and @wester_axel! Many thanks to the great host! @APASLnews

Important retrospective study that suggest that GLP-1 agonists may have benefit in improving hepatic morbidity and mortality @JasmohanBajaj @MichiganLiver @LiverFellow

Read the paper by @wester_axel et al on "Glucagon-like peptide-1 receptor agonists + risk of major adverse liver outcomes in patients with chronic liver disease + type 2 diabetes" via bit.ly/47OtXsQ @hanneshagstrom @yingshang1 @_tony_matthews @karolinskainst #GLP1

GLP-1 medications and the risk of major adverse liver outcomes #MALO in patients with chronic liver disease and type 2 #diabetes. gut.bmj.com/content/early/…

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes | Gut gut.bmj.com/content/early/…

Read the paper by @wester_axel et al on "Glucagon-like peptide-1 receptor agonists + risk of major adverse liver outcomes in patients with chronic liver disease + type 2 diabetes" via bit.ly/47OtXsQ @hanneshagstrom @yingshang1 @_tony_matthews @karolinskainst #GLP1

#GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 #diabetes and chronic liver disease, finds a new KI study by @wester_axel and @hanneshagstrom published in @Gut_BMJ. #Hepatology news.ki.se/popular-diabet…

1/2 📚 Patients with non-alcoholic fatty liver disease (NAFLD) have a ⬆️ rate and risk of severe infections compared to the general population 👀 The risk was independent of other metabolic syndrome components 🔓 bit.ly/3two5Gb #livertwitter

Alcohol-related #cirrhosis cuts 14 years off the life expectancy of men and 16 for women journals.lww.com/hepcomm/fullte… #livertwitter What @HannesHagstrom is doing with Swedish data is so important

Data from @karolinskainst show that PBC patients have higher risk of cancer, mostly driven by HCC but with a signal on lymphoma that deserves attention @EASLedu @ERN_RARE_LIVER #LiverTwitter #ilc2023

A huge unmet need for quality improvement in #cirrhosis care is in the transition from hospital to home; aftercare following decompensation, secondary prophylaxis 💪work from @HannesHagstrom @yingshing @wester_axel & Linnea Widman #livertwitter cghjournal.org/article/S1542-…

Patients with alcohol-related cirrhosis have an almost 4-fold increased fracture rate as well as an increased 30-day and 1-year postfracture mortality rate compared with the general population. Study in @AGA_CGH. @wester_axel @HannesHagstrom #GItwitter fal.cn/3rjMr

In a Swedish nationwide population-based cohort study, the risk of fractures in NAFLD was similar to the general population. This suggests that broad surveillance of fracture risk factors in NAFLD is not motivated. ✏️@hanneshagstrom @wester_axel 📰onlinelibrary.wiley.com/doi/10.1111/jo…

Limited usefulness of PRECISE-DAPT for high bleeding risk patients with myocardial infarction in SWEDEHEART. ow.ly/NwnY50GviQ2 @wester_axel @lunduniversity

New article: Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study link.paperbirds.me/S92wL2 #kidneycancer #oncology

Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study pubmed.ncbi.nlm.nih.gov/34612051/?utm_…

#Anemia constitutes a high‐risk feature in patients with #acute #coronary #syndromes ow.ly/g8ON30plNHq #AHAJournals

Coronariografía tras PCR en SCASEST demuestra lesiones coronarias severas en 43,9% pero no produce beneficio su realización temprana. resuscitationjournal.com/article/S0300-…